US-based Tauriga Sciences has signed a manufacturing agreement with a Maryland-based gum manufacturer for the production of its Cannabis/CBD chewing gum product line (CBD Gum).
The manufacturer will produce Tauriga’s CBD Gum as per the specifications in an agreement that stood since 28 December 2018.
Tauriga has already paid a majority portion of the cost associated with the initial production run of 8,700 units. Each unit contains eight pieces of CBD gum.
The CBD gum will contain 10 mg of CBD Isolate and the initial production run will feature mint flavour.
A third party will test every batch on aspects such as CBD label content, THC content (0%) and microbiology.
Packaging intended for the retail market will consist of eight gum tablet count and a blister card labelled with the lot number and expiration date.
The outer sleeve of the product will feature Tauriga’s artwork, graphic designs and label copy.
Tauriga is required to provide the manufacturer with the graphic design artwork, logo, label design and implement Kosher certification process.
Tauriga Sciences CEO Seth Shaw said: “Tauriga Sciences Inc has evaluated a number of potential opportunities during the calendar year 2018. The company believes that it has identified a potentially lucrative niche market to address, for its shareholders, and is moving forward with great enthusiasm to develop and market its CBD Gum product line.”
The firm expects to generate revenue from its CBD Gum during the latter part of the current operating quarter, which runs from 1 January to 31 March.
